-transparent.png){kind=logo}
Sixty members of 4 families prone to cutaneous malignant melanoma (CMM) and a genetically determined precursor nevus syndrome underwent extensive immunologic evaluation. The most consistent finding was a diminished in vitro response to pooled alloantigens in the one-way mixed leukocyte culture (MLC) and a tendency to low T-lymphocyte and B-lymphocyte levels. When compared to controls, low B-lymphocyte levels and reduced MLC responses were found not only in family members with CMM and/or precursor nevi but also in unaffected blood relatives and spouses. The genesis of the immune dysfunction and its possible relationship to melanoma pathogenesis remain to be clarified.
Related Publications
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
September 2018,
Cancer,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
March 1993,
The Journal of investigative dermatology,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
November 1979,
Journal of the National Cancer Institute,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
July 2008,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
December 1999,
Archives of dermatology,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
April 1985,
Annals of internal medicine,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
September 1999,
Clinical genetics,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
October 1995,
Journal of the American Academy of Dermatology,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
July 2018,
The Journal of investigative dermatology,
J H Dean, and
M H Greene, and
R R Reimer, and
F V LeSane, and
E A McKeen, and
J J Mulvihill, and
W A Blattner, and
R B Herberman, and
J F Fraumeni
September 2018,
Genetics in medicine : official journal of the American College of Medical Genetics,
